Alaunos Therapeutics (TCRT) Q1 2026 Annual Earnings

Screener

Reported May 15, 2026 · After market close

EPS-$0.59

Next report

Nov 17, 2026 (in 2 months)

EPS estimate-$15.75

Versus estimates

Revenue

Q4 2025$3.0KIn line Q1 2025$2.0K

Diluted EPS

Q1 2026-$0.59

Q4 2025-$0.40Beat by $3.29 Q3 2025-$0.55Beat by $4.35 Q2 2025-$0.63Beat by $4.70 Q1 2025-$0.67Beat by $5.77

FAQ

When did Alaunos Therapeutics report Q1 2026 earnings?: Alaunos Therapeutics (TCRT) reported Q1 2026 earnings on May 15, 2026 after market close.
What were Alaunos Therapeutics's Q1 2026 revenue and EPS?: Alaunos Therapeutics reported eps of $-0.59 for Q1 2026.
How did Alaunos Therapeutics's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, eps grew 11.9% from $-0.67.
Where can I find Alaunos Therapeutics's Q1 2026 SEC filings?: You can read the 10-K periodic report (0001193125-26-134720) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Alaunos Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk